Nasal Cavity Lymphoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: NSL004 MIFTS: 32	Nasal Cavity Lymphoma Categories: Blood diseases, Cancer diseases, Immune diseases, Respiratory diseases
Genes Tissues Related diseases Publications Pathways Drugs Expand all tables

Sources

Aliases & Classifications for Nasal Cavity Lymphoma

MalaCards integrated aliases for Nasal Cavity Lymphoma:

Name: Nasal Cavity Lymphoma ¹² ¹⁵ ⁷¹

Lymphoma of the Nasal Cavity ¹²

Lymphoma of Nasal Cavity ¹²

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Immune diseases Blood diseases Respiratory diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:10813

NCIt ⁴⁹ C6074

UMLS ⁷¹ C1334921

Sources

Summaries for Nasal Cavity Lymphoma

MalaCards based summary : Nasal Cavity Lymphoma, also known as lymphoma of the nasal cavity, is related to b-cell lymphoma and diffuse large b-cell lymphoma. An important gene associated with Nasal Cavity Lymphoma is SCYL1 (SCY1 Like Pseudokinase 1), and among its related pathways/superpathways are NF-kappaB Signaling and Hematopoietic Stem Cells and Lineage-specific Markers. The drugs Etoposide and Ifosfamide have been mentioned in the context of this disorder. Affiliated tissues include t cells, b cells and kidney, and related phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and Synthetic lethal with MLN4924 (a NAE inhibitor)

Sources

Related Diseases for Nasal Cavity Lymphoma

Diseases related to Nasal Cavity Lymphoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 107)

#	Related Disease	Score	Top Affiliating Genes
1	b-cell lymphoma	30.2	TIA1 CDKN2A CD5 BCL6
2	diffuse large b-cell lymphoma	30.0	CDKN2A CD5 BCL6 B2M
3	lymphoblastic lymphoma	29.8	CDKN2A CD5 BCL6
4	lymphoma, hodgkin, classic	29.4	TIA1 GZMB BCL6
5	lymphoma	29.1	TIA1 GZMB CDKN2A CD5 BCL6 B2M
6	lymphoma, non-hodgkin, familial	26.8	PRF1 NCAM1 IGHV4-38-2 GZMB CDKN2A CD5
7	solitary osseous plasmacytoma	10.4	NCAM1 B2M
8	orbit lymphoma	10.4	TIA1 NCAM1
9	papillary thymic adenocarcinoma	10.4	NCAM1 CD5
10	infected hydrocele	10.4	NCAM1 B2M
11	soft palate cancer	10.4	CDKN2A B2M
12	laryngeal small cell carcinoma	10.4	NCAM1 CDKN2A
13	cranial nerve neoplasm	10.3	SCRT1 NCAM1
14	mediastinal cancer	10.3	NCAM1 CD5
15	extramedullary plasmacytoma	10.3	NCAM1 B2M
16	bile duct adenoma	10.3	NCAM1 CDKN2A
17	chronic dacryoadenitis	10.3	SCYL1 IGHV4-38-2
18	paranasal sinus lymphoma	10.3	SCYL1 BCL6
19	retina lymphoma	10.3	SCYL1 IGHV4-38-2
20	parapsoriasis	10.3	CD5 CD2
21	lymphohistiocytoid mesothelioma	10.3	CDKN2A CD5
22	bladder lymphoma	10.2	CD5 BCL6
23	monoclonal paraproteinemia	10.2	NCAM1 IGHV4-38-2
24	prostate lymphoma	10.2	CD5 BCL6
25	epiglottis neoplasm	10.2	CD5 BCL6
26	lung lymphoma	10.2	CD5 BCL6
27	bone lymphoma	10.2	CD5 BCL6
28	colon lymphoma	10.2	CD5 BCL6
29	appendix lymphoma	10.2	CD5 BCL6
30	lymphomatoid granulomatosis	10.2	TIA1 GZMB
31	breast lipoma	10.2	TIA1 GZMB
32	primary cutaneous anaplastic large cell lymphoma	10.2	TIA1 GZMB
33	adult lymphoma	10.2	CD5 BCL6
34	lichen sclerosus et atrophicus	10.1	TIA1 GZMB
35	hepatosplenic t-cell lymphoma	10.1	TIA1 GZMB
36	plasmablastic lymphoma	10.1	CDKN2A BCL6
37	primary cutaneous b-cell lymphoma	10.1	CDKN2A BCL6
38	gastrointestinal lymphoma	10.1	NCAM1 CD5 BCL6
39	lymphocytic gastritis	10.1	TIA1 GZMB
40	lymphomatoid papulosis	10.1	TIA1 GZMB
41	t-cell adult acute lymphocytic leukemia	10.1	TIA1 CD5 CD2
42	t-cell lymphoma, subcutaneous panniculitis-like	10.1	TIA1 GZMB
43	non-secretory myeloma	10.1	NCAM1 IGHV4-38-2 B2M
44	intravascular large b-cell lymphoma	10.1	CD5 BCL6 B2M
45	smoldering myeloma	10.1	NCAM1 IGHV4-38-2 B2M
46	chest wall lymphoma	10.1	IGHV4-38-2 BCL6
47	follicular lymphoma	10.1
48	rhinitis	10.1
49	monoclonal gammopathy of uncertain significance	10.1	NCAM1 IGHV4-38-2 B2M
50	blood protein disease	10.1	NCAM1 IGHV4-38-2 B2M

Graphical network of the top 20 diseases related to Nasal Cavity Lymphoma:

Sources

Symptoms & Phenotypes for Nasal Cavity Lymphoma

GenomeRNAi Phenotypes related to Nasal Cavity Lymphoma according to GeneCards Suite gene sharing:

²⁶

#	Description	GenomeRNAi Source Accession	Score	Top Affiliating Genes
1	Synthetic lethal with MLN4924 (a NAE inhibitor)	GR00250-A-1	9.32	CD2 CDKN2A GZMB PSMB8 TCOF1
2	Synthetic lethal with MLN4924 (a NAE inhibitor)	GR00250-A-2	9.32	CD2 CDKN2A GZMB PSMB8 TCOF1

MGI Mouse Phenotypes related to Nasal Cavity Lymphoma:

⁴⁵

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	hematopoietic system	MP:0005397	9.32	ANKRD11 B2M BCL6 CD5 CDKN2A ERF

Sources

Drugs & Therapeutics for Nasal Cavity Lymphoma

Drugs for Nasal Cavity Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 9)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Etoposide

Approved

Phase 2

33419-42-0

36462

Synonyms:

(−)-etoposide

(-)-Etoposide

121471-01-0

136598-18-0

201594-04-9

33419-42-0

35317-32-9

4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-b-D-glucopyranoside)

4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)

4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-β-D-glucopyranoside)

4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside)

4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside

4-Demethylepipodophyllotoxin b-D-ethylideneglucoside

4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside

4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside

4-demethylepipodophyllotoxin β-D-ethylideneglucoside

4-Demethylepipodophyllotoxin β-D-ethylideneglucoside

4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside

4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin

51854-34-3

76576-58-4

9-((4,6-O-Ethylidine-b-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one

9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one

9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one

9-((4,6-O-Ethylidine-β-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one

AB00438905

AC1L1FN8

AC1L1VT3

AC1L6246

AC1NR4OG

AC1O4WGG

AC1O7M1N

AC1Q47JJ

alpha-D-Glucopyranosyl isomer etoposide

Ambap33419-42-0

Baxter brand OF etoposide

Baxter oncology brand OF etoposide

Bio1_000489

Bio1_000978

Bio1_001467

BPBio1_000673

BRD-K37798499-001-02-5

Bristol myers brand OF etoposide

Bristol myers squibb brand OF etoposide

Bristol-myers brand OF etoposide

Bristol-myers squibb brand OF etoposide

BSPBio_000611

C01576

CCRIS 2392

Celltop

CHEBI:4911

CHEBI:588795

CHEMBL44657

CID11758093

CID284997

CID3310

CID36462

CID5284558

CID6419930

CID6610299

CPD000112002

D00125

DB00773

DEMETHY-EPIPODOPHYLLOTOXIN,ETHYLIDENE GLUCOSIDE,

Demethyl epipodophyllotoxin ethylidine glucoside

Demethyl Epipodophyllotoxin Ethylidine Glucoside

Demethyl-epiodophyllotoxin ethylidene glucoside

Demethylepipodophyllotoxin-beta-D-ethylideneglucoside

E0675

E1383_SIGMA

EINECS 251-509-1

Epipodophyllotoxin VP-16213

Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside

Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside

Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI)

Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside)

Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside)

Eposide

Eposin

Eposin, Vepesid, VP-16, Toposar, Etoposide

eto GRY

eto-GRY

Etomedac

ETOP

Etopol

Etopophos

Etopophos (phosphate salt)

Etopos

etoposide

Etoposide

Etoposide (JP15/USP/INN)

Etoposide (VP16)

Etoposide [USAN:INN:BAN:JAN]

Etoposide pierre fabre

Etoposide teva

Etoposide, (5a alpha)-isomer

Etoposide, (5a alpha,9 alpha)-isomer

Etoposide, (5S)-isomer

Etoposide, alpha D glucopyranosyl isomer

Etoposide, alpha-D-glucopyranosyl isomer

Etoposido

Etoposido [INN-Spanish]

etoposido Ferrer farma

Etoposidum

Etoposidum [INN-Latin]

Etosid

Exitop

Ferrer brand OF etoposide

Gry brand OF etoposide

HMS1569O13

HMS2052N05

HMS2089F14

HSDB 6517

I06-0248

KBioSS_002410

Lastet

Lemery brand OF etoposide

LS-1214

Medac brand OF etoposide

MLS000049957

MLS001074951

MLS001424283

MLS002153463

MLS002207239

MLS002222184

MolPort-003-983-431

MolPort-004-905-001

MolPort-004-955-161

NCGC00025056-02

NChemBio.2007.10-comp19

nchembio.573-comp8

nchembio873-comp2

NK 171

Novartis brand OF etoposide

NSC 141540

NSC141540

NSC-141540

Onkoposid

Onkoworks brand OF etoposide

Pharmachemie brand OF etoposide

Pierre fabre brand OF etoposide

Prasfarma brand OF etoposide

Prestwick_211

Prestwick0_000396

Prestwick1_000396

Prestwick2_000396

Prestwick3_000396

Riboposid

Ribosepharm brand OF etoposide

S1225_Selleck

SAM001246880

Sanfer brand OF etoposide

SMR000112002

SPBio_002532

ST056353

Tedec meiji brand OF etoposide

Teva brand OF etoposide

Toposar

trans-Etoposide

UNII-6PLQ3CP4P3

Vepesid

VePesid

VePESID (TN)

Vepesid J

Vepeside

Vépéside sandoz

Vépéside-sandoz

VP 16

VP 16 (pharmaceutical)

VP 16213

VP 16-213

VP-16

VP-16-213

ZINC03830818

ZINC03938684

Zuyeyidal

Ifosfamide

Approved

Phase 2

3778-73-2

3690

Synonyms:

(+-)-Ifosfamid

(+-)-Ifosphamide

(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide

(D,L)-Ifosfamide

(R,S)-Ifosphamide

(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide

{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,

1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide

1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide

2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd

2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd

2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide

2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide

2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide

2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI)

2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide

3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide

3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide

3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide

3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide

3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide

3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide

3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide

3,} 2-oxazaphosphorine oxide

36341-88-5

3778-73-2

84711-20-6

A 4942

AB00513932

AC1L1GHW

AC-2113

Ambap3778-73-2

Asta Z 4942

ASTA Z 4942

BPBio1_000865

BRN 0611835

BSPBio_000785

C07047

CAS-3778-73-2

CCRIS 352

CHEBI:5864

CHEMBL1024

CID3690

Cyfos

D00343

D007069

DB01181

EINECS 223-237-3

HMS1570H07

HMS2090M12

HMS2093N07

Holoxan

Holoxan 1000

HSDB 7023

I06-0494

Ifex

IFEX (TN)

Ifosfamid

Ifosfamida

Ifosfamida [INN-Spanish]

ifosfamide

Ifosfamide

Ifosfamide (JAN/USP/INN)

Ifosfamide [USAN:INN:BAN:JAN]

Ifosfamide sterile

Ifosfamide Sterile

Ifosfamidum

Ifosfamidum [INN-Latin]

Ifosphamide

Ifsofamide

Iphosphamid

Iphosphamid(e)

Iphosphamide

I-phosphamide

I-Phosphamide

iso Endoxan

Iso Endoxan

iso-Endoxan

Isoendoxan

Iso-Endoxan

Isofosfamide

Isophosphamide

isosfamide

Isosfamide

LS-102

LS-99799

Mitoxana

Mitoxana, Ifex, Ifosfamide

MJF 9325

MJF-9325

MLS002154021

MolPort-003-666-704

N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid

N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German]

N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide

N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide

N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide

N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide

N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine

N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide

N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide

N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide

Naxamide

NCGC00016639-01

NCGC00179435-01

NCI60_000233

NCI-C01638

NPFAPI-04

NSC 109,724

NSC 109724

NSC109,724

NSC-109,724

NSC109724

NSC-109724

Prestwick0_000833

Prestwick1_000833

Prestwick2_000833

Prestwick3_000833

S1302_Selleck

SMR001233348

SPBio_002706

STL058690

UNII-UM20QQM95Y

WLN: T6NPOTJ AM2G BO B2G

Z 4942

Z4942

Z-4942

Dexamethasone acetate

Approved, Investigational, Vet_approved

Phase 2

1177-87-3

Dexamethasone

Approved, Investigational, Vet_approved

Phase 2

50-02-2

5743

Synonyms:

(3H)-Dexamethasone

.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol

.gamma.corten

137098-19-2

16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol

16.alpha.-Methyl-9.alpha.-fluoroprednisolone

16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol

16alpha -Methyl-9alpha -fluoroprednisolone

16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol

16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol

16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone

16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone

16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone

16alpha-Methyl-9alpha-fluoroprednisolone

16-alpha-Methyl-9-alpha-fluoroprednisolone

16a-Methyl-9a-fluoro-1-dehydrocortisol

16α-methyl-9α-fluoro-1-dehydrocortisol

16α-Methyl-9α-fluoro-1-dehydrocortisol

1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone

1-dehydro-16alpha -Methyl-9alpha -fluorohydrocortisone

1-dehydro-16alpha-Methyl-9alpha-fluorohydrocortisone

1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone

1-dehydro-16a-Methyl-9a-fluorohydrocortisone

1-dehydro-16α-methyl-9α-fluorohydrocortisone

1-Dehydro-16α-methyl-9α-fluorohydrocortisone

23495-06-9

31375_FLUKA

46165_FLUKA

46165_RIEDEL

50-02-2

8054-59-9

9.alpha.-Fluoro-16.alpha.-methylprednisolone

906422-84-2

9a-fluoro-16a-Methylprednisolone

9a-fluoro-16BETA-METHYLPREDNISOLONE

9A-FLUORO-16BETA-METHYLPREDNISOLONE

9alpha -fluoro-16alpha -Methylprednisolone

9alpha-fluoro-16alpha-Methylprednisolone

9alpha-fluoro-16alpha-Methyl-prednisolone

9-alpha-fluoro-16-alpha-Methylprednisolone

9alpha-Fluoro-16alpha-methylprednisolone

9-alpha-Fluoro-16-alpha-methylprednisolone

9-fluoro-11,17,21-Trihydroxy-16-methylpregna-1,4-diene-3,20-dione

9-fluoro-11alpha -Methylpregna-1,4-diene-3,20-dione

9-fluoro-16-Methylprednisolone

9α-fluoro-16α-methylprednisolone

9α-Fluoro-16α-methylprednisolone

AC-11056

AC1L1L1H

AC1Q29DM

Adexone

Aeroseb-D

Aeroseb-dex

Aeroseb-Dex

AI3-50934

Ak dex OPH otic soln 0.1%

Alcon brand OF dexamethasone

Alcon Brand of Dexamethasone

alpha -fluoro-16-alpha -Methylcortisol

Anaflogistico

Aphtasolon

Aphthasolone

apo-Dexamethasone

Auxiron

Azimycin (veterinary)

Azium

Azium (veterinary)

Azium (Veterinary)

BIDD:ER0494

BIDD:PXR0060

Bisu Ds

Bisu DS

BRD-K38775274-001-02-3

BRD-K38775274-001-06-4

BSPBio_000995

C15643

C22H29FO5

Calonat

CCRIS 7067

CHEBI:41879

CHEMBL384467

CID5743

Corson

Corsone

Cortisumman

CPD001227192

CPD-10549

D00292

D003907

D1756_SIGMA

D4902_SIGMA

D6645_SIGMA

D8893_SIGMA

D9184_SIGMA

DB01234

Decacort

Decacortin

Decaderm

Decadron

Decadron (TN)

Decadron Tablets, Elixir

Decadron, Dexamethasone

Decadron-La

Decadron-LA

Decagel

Decaject

Decaject l.a.

Decaject L.A.

Decaject-l.a.

Decaject-L.A.

Decalix

Decameth

Decasone

Decaspray

Dectancyl

Dekacort

delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol

delta1-9alpha-Fluoro-16alpha-methylcortisol

Delta1-9alpha-fluoro-16alpha-Methylcortisol

Deltafluorene

Dergramin

Deronil

Desadrene

Desametasone

Desametasone [Dcit]

Desametasone [DCIT]

Desamethasone

Desameton

Deseronil

DEX

Dexa

DEXA

Dexa mamallet

Dexa Mamallet

Dexacen-4

Dexacidin

Dexacort

Dexacortal

Dexa-cortidelt

Dexa-Cortidelt

Dexacortin

Dexa-cortisyl

Dexa-Cortisyl

Dexadeltone

Dexafarma

Dexair

Dexalona

Dexaltin

Dexa-Mamallet

Dexametasona

Dexametasona [INN-Spanish]

Dexametasone

Dexameth

Dexamethansone

dexamethasone

Dexamethasone

Dexaméthasone

Dexamethasone (JP15/USP/INN)

Dexamethasone [INN:BAN:JAN]

Dexamethasone acetate

Dexamethasone Acetate

Dexamethasone alcohol

Dexamethasone Alcohol

Dexamethasone base

Dexamethasone Base

Dexamethasone intensol

Dexamethasone Intensol

Dexamethasone sodium phosphate

Dexamethasone Sodium Phosphate

Dexamethasone-omega

Dexamethasonum

Dexamethasonum [INN-Latin]

Dexamethazone

Dexamonozon

Dexapolcort

Dexapos

Dexaprol

Dexa-scheroson

Dexa-Scheroson

Dexa-sine

Dexa-Sine

Dexason

Dexasone

Dexasone 0.5MG

Dexasone 0.75MG

Dexasone 4MG

Dexasporin

Dex-ide

Dex-Ide

Dexinolon

Dexinoral

Dexone

Dexone 0.5

DEXONE 0.5

Dexone 0.75

DEXONE 0.75

Dexone 1.5

DEXONE 1.5

Dexone 4

DEXONE 4

Dexonium

Dexpak

Dextelan

Dezone

Dinormon

DXM

Dxms

DXMS

ECR brand OF dexamethasone

ECR Brand of Dexamethasone

EINECS 200-003-9

Fluormethylprednisolone

Fluormone

Fluorocort

Fortecortin

Foy brand OF dexamethasone

Foy Brand of Dexamethasone

FT-0080377

Gammacorten

Hexadecadrol

Hexadrol

Hexadrol elixir

Hexadrol Elixir

Hexadrol Tablets

Hl-dex

Hl-Dex

HL-Dex

HMS1792A17

HMS1990A17

HMS2089N13

HSDB 3053

I06-1196

ICN brand OF dexamethasone

ICN Brand of Dexamethasone

IontoDex

isopto-Dex

Isopto-Dex

Lokalison F

Loverine

LS-7300

Luxazone

Maxidex

Maxidex ont 0.1%

Maxidex sus 0.1%

Maxitrol

Mediamethasone

Merck brand OF dexamethasone

Merck Brand of Dexamethasone

Merz brand 1 OF dexamethasone

Merz Brand 1 of Dexamethasone

Merz brand 2 OF dexamethasone

Merz Brand 2 of Dexamethasone

Methylfluorprednisolone

Mexidex

Millicorten

MK 125

MLS001055412

MLS001332507

MLS001332508

MolMap_000018

MolPort-003-846-433

Mymethasone

Naquasone (veterinary)

NCGC00091019-01

NCGC00091019-02

NCGC00091019-03

NCGC00091019-04

NCGC00091019-05

nchembio809-comp2

NCI60_003067

Neomycin and polymyxin b sulfates and dexamethasone

Neomycin and polymyxin b sulphates and dexamethasone

NSC 34521

NSC34521

Ocu-trol

Ocu-Trol

Oradexon

OTO-104

Pet derm III

Pet Derm Iii

Pet Derm III

Pet-Derm Iii

PHL-Dexamethasone

PMS Dexamethasone elixir 0.5mg/5ML

PMS-Dexamethasone

Policort

Posurdex

Prednisolon F

Prednisolone F

Prodex

S1322_Selleck

SAM002548948

Sandoz dexamethasone

SGCUT00126

Sk-Dexamethasone

SK-Dexamethasone

SMP1_000092

SMR000857119

SMR001227192

Spectrum5_002019

Spoloven

ST50307091

Sunia sol D

Sunia Sol D

Superprednol

TL8003317

to_000038

Tobradex

Tobramycin and dexamethasone

Tresaderm (veterinary)

Turbinaire

UNII-7S5I7G3JQL

Visumetazone

WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1

ZINC03875332

Pembrolizumab

Approved

Phase 2

1374853-91-4

Etoposide phosphate

Phase 2

Isophosphamide mustard

Phase 2

Synonyms:

Ifosfamide mustard

Ifosforamide mustard

IPAM

Iphosphoramide mustard

Isophosphamide mustard

Isophosphoramide mustard

N,N'-di-(2-chloroethyl)phosphorodiamidic acid

NN'-Bis-(2-chloroethyl)phosphate

NN'-Bis-(2-chloroethyl)phosphoric acid

Palifosfamide-tris

zio-201Isophosphamide mustard

asparaginase

Phase 2

Antineoplastic Agents, Immunological

Phase 2

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	Open-labeled, Multicenter Phase II Study of Concomitant Chemo-radiotherapy Followed by VIDL Chemotherapy With Risk-based Application of Autologous Stem Cell Transplantation in Stage I/II Extranodal NK/T-cell Lymphoma	Completed	NCT01007526	Phase 2
2	Pilot Study of Pembrolizumab in Untreated Extranodal, NK/T Cell Lymphoma, Nasal Type	Recruiting	NCT03728972	Phase 2	Pembrolizumab

Search NIH Clinical Center for Nasal Cavity Lymphoma

Sources

Genetic Tests for Nasal Cavity Lymphoma

Sources

Anatomical Context for Nasal Cavity Lymphoma

MalaCards organs/tissues related to Nasal Cavity Lymphoma:

⁴⁰

T Cells, B Cells, Kidney, Nk Cells

Sources

Publications for Nasal Cavity Lymphoma

Articles related to Nasal Cavity Lymphoma:

(show all 45)

#	Title	Authors	PMID	Year
1	Identification of A Novel Papillomavirus Associated with Squamous Cell Carcinoma in A Domestic Cat. ⁶¹	Carrai M...Beatty JA	31968684	2020
2	Extranodal natural killer/T-cell lymphoma nasal type with central nervous system involvement mimicked tuberculous meningitis: A case report. ⁶¹	Yang Y...Liang H	31441847	2019
3	[Clinical differences between primary nasopharyngeal NK/T-cell lymphoma and primary nasal cavity NK/T-cell lymphoma with nasopharynx extension]. ⁶¹	Liu WX...Li YX	30678418	2019
4	Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder. ⁶¹	Furuya G...Fukayama M	29843925	2018
5	Lymphoma of the nasal cavity and paranasal sinuses: A case series. ⁶¹	Steele TO...Smith TL	27657899	2016
6	Nasal dissemination of a single-clone IgH-rearranged conjunctival MALT lymphoma through the nasolacrimal duct: A case report. ⁶¹	Hsieh CY...Lee F	27446385	2016
7	T-cell lymphoma in the nasal cavity of a Brown Swiss heifer. ⁶¹	Braun U...Sydler T	25886837	2015
8	Sinonasal lymphoma: case series and review of the literature. ⁶¹	Peng KA...Wang MB	24760602	2014
9	[Radiation therapy of sinonasal natural killer/T-cell lymphoma]. ⁶¹	Riet FG...Feuvret L	24462054	2014
10	Diffuse large B-cell lymphoma of the nasal cavity presenting as abducens nerve palsy. ⁶¹	Kang JW...Kim JH	24220442	2013
11	[Clinical analysis of 20 patients with primary non-Hodgkin's lymphoma of nasal cavity and nasopharynx]. ⁶¹	Abulajiang...Gu X	24459928	2013
12	NK/T-cell lymphoma of the nasal cavity causing contralateral dacryoadenitis. ⁶¹	Luemsamran P...Vangveeravong S	23663138	2013
13	Pathology in practice. Nonepitheliotropic B-cell lymphoma of the nasal cavity with associated suppurative rhinitis and epidermal ulceration and lymphoma of the right kidney. ⁶¹	Lane LV...Njaa BL	22380803	2012
14	Aggressive sinonasal natural killer/T-cell lymphoma with hemophagocytic lymphohistiocytosis. ⁶¹	Turner JH...Lin SY	21764176	2012
15	The simultaneous appearance of a nasal natural killer-cell lymphoma and acute myelogenous leukemia. ⁶¹	Van Crombrugge L...Kerre T	22545391	2012
16	Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy. ⁶¹	Guo Y...Li J	17306611	2008
17	[Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases]. ⁶¹	He YF...Guan ZZ	17166382	2006
18	EBV-associated nasal-type NK/T-cell lymphoma of the nasal cavity/paranasal sinus in a renal allograft recipient. ⁶¹	Momose A...Funyu T	16364984	2006
19	[Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases]. ⁶¹	Yao B...Yu ZH	16613682	2006
20	[Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity]. ⁶¹	Yao B...Liu XF	16737624	2006
21	[Angiocentric lymphoma of the face: report of the 2 cases]. ⁶¹	Amaoui B...El Gueddari BK	14522352	2003
22	Mortality among chrome leather tannery workers: an update. ⁶¹	Stern FB	12874853	2003
23	Lymphoma of the nasal cavity and paranasal sinuses: treatment and outcome of early-stage disease. ⁶¹	Proulx GM...Wang CC	12576916	2003
24	[Lymphoma of the nasal cavity, clinical and anatomo-pathologic considerations]. ⁶¹	Marquez F...Rivas C	12733318	2003
25	Primary non-Hodgkin's lymphoma of the nose and paranasal sinuses: a case report. ⁶¹	Murthy VS...Munishwara GB	15027735	2003
26	Localized aggressive non-Hodgkin's lymphoma of the nasal cavity: a survey by the Japan Lymphoma Radiation Therapy Group. ⁶¹	Shikama N...Hayabuchi N	11728681	2001
27	[Natural killer cell nasal lymphoma mimicking localized Wegener's disease]. ⁶¹	Dilhuydy MS...Pellegrin JL	11433567	2001
28	[Multivariate analysis of prognosis of patients with stage IE non-Hodgkin's lymphomas of the nasal cavity]. ⁶¹	Hu W...Luo F	11783097	2001
29	[A rare case of malignant lymphoma of the nasal cavity and paranasal sinuses]. ⁶¹	Teresinska E...Kowalczyk J	11494739	2001
30	Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patients. ⁶¹	Aviles A...Talavera A	11012633	2000
31	Primary non-Hodgkin's lymphoma of the nasal cavity. Clinical case report and discussion. ⁶¹	Cavalot AL...Fadda GL	10958410	2000
32	Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. ⁶¹	Li YX...Huang YR	9690537	1998
33	Clinical stage IE primary lymphoma of the nasal cavity: radiation therapy and chemotherapy. ⁶¹	Shikama N...Ishii K	9240537	1997
34	Lymphoma of the nasal cavity and paranasal sinuses: improved outcome and altered prognostic factors with combined modality therapy. ⁶¹	Logsdon MD...Cox JD	9241082	1997
35	[A clinical and pathological study of non-Hodgkin's lymphoma of the nasal cavity and paranasal sinuses]. ⁶¹	Hashimoto S...Nojima T	8337110	1993
36	[Non-Hodgkin's lymphoma of the nasal cavity and paranasal sinuses: clinicopathologic study of ten cases]. ⁶¹	Chubachi A...Watanuki T	1890745	1991
37	[A clinical study of non-Hodgkin's lymphoma of the nasal cavity and paranasal sinus]. ⁶¹	Takenaka T...Ohyama W	3249114	1988
38	Primary lymphoma of the nasal cavity. A case report. ⁶¹	Santopietro R...Luzi P	3616212	1987
39	[Radiotherapy of non-Hodgkin's lymphoma of the nasal cavity--report of 48 cases]. ⁶¹	Gu DZ	3915458	1985
40	A comparative analysis of lymphomas involving Waldeyer's ring and the nasal cavity and paranasal sinuses. ⁶¹	Robbins KT...Goepfert H	4068097	1985
41	[Malignant lymphoma of the nasal cavity]. ⁶¹	Kristensen S...Nielsen F	6515888	1984
42	Computed tomography of sinonasal non-Hodgkin lymphoma. ⁶¹	Kondo M...Hashimoto S	6707267	1984
43	[Lymphoma of the nasal cavity. Review of 62 cases]. ⁶¹	Gutierrez Romero M...Gonzalez Constandse R	6718825	1984
44	[Light and electron microscopic observation on malignant lymphoma of the nasal cavity--a case report]. ⁶¹	Li TS	6745058	1984
45	Diagnosis of malignant lymphomas of the nasal cavity, paranasal sinuses and nasopharynx. ⁶¹	Duncavage JA...Malin TC	6621224	1983

Sources

Genes for Nasal Cavity Lymphoma

Genes related to Nasal Cavity Lymphoma (0 elite genes):

(show all 18)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	SCYL1	SCY1 Like Pseudokinase 1	Protein Coding	6.6	DISEASES inferred ¹⁵
2	ANKRD11	Ankyrin Repeat Domain 11	Protein Coding	5.82	DISEASES inferred ¹⁵
3	NCAM1	Neural Cell Adhesion Molecule 1	Protein Coding	5.27	DISEASES inferred ¹⁵
4	SCRT1	Scratch Family Transcriptional Repressor 1	Protein Coding	5.09	DISEASES inferred ¹⁵
5	NPB	Neuropeptide B	Protein Coding	5.05	DISEASES inferred ¹⁵
6	ERF	ETS2 Repressor Factor	Protein Coding	4.92	DISEASES inferred ¹⁵
7	NISCH	Nischarin	Protein Coding	4.45	DISEASES inferred ¹⁵
8	B2M	Beta-2-Microglobulin	Protein Coding	4.45	DISEASES inferred ¹⁵
9	CD5	CD5 Molecule	Protein Coding	4.2	DISEASES inferred ¹⁵
10	TIA1	TIA1 Cytotoxic Granule Associated RNA Binding Protein	Protein Coding	4.15	DISEASES inferred ¹⁵
11	CDKN2A	Cyclin Dependent Kinase Inhibitor 2A	Protein Coding	4.06	DISEASES inferred ¹⁵
12	CD2	CD2 Molecule	Protein Coding	3.6	DISEASES inferred ¹⁵
13	TCOF1	Treacle Ribosome Biogenesis Factor 1	Protein Coding	3.51	DISEASES inferred ¹⁵
14	BCL6	BCL6 Transcription Repressor	Protein Coding	3.47	DISEASES inferred ¹⁵
15	GZMB	Granzyme B	Protein Coding	3.41	DISEASES inferred ¹⁵
16	PSMB8	Proteasome 20S Subunit Beta 8	Protein Coding	3.41	DISEASES inferred ¹⁵
17	PRF1	Perforin 1	Protein Coding	3.38	DISEASES inferred ¹⁵
18	IGHV4-38-2	Immunoglobulin Heavy Variable 4-38-2	Protein Coding	3.3	DISEASES inferred ¹⁵

Sources

Variations for Nasal Cavity Lymphoma

Sources

Expression for Nasal Cavity Lymphoma

Search GEO for disease gene expression data for Nasal Cavity Lymphoma.

Sources

Pathways for Nasal Cavity Lymphoma

Pathways related to Nasal Cavity Lymphoma according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	NF-kappaB Signaling ⁴	11.61	PSMB8 NCAM1 GZMB CD2 BCL6 B2M
2	Hematopoietic Stem Cells and Lineage-specific Markers ⁶⁴	11.4	NCAM1 CD5 CD2
3	Downstream signaling in naive CD8+ T cells ¹ Show member pathways Ras signaling in the CD4+ TCR pathway ¹	10.92	PRF1 GZMB B2M

Sources

GO Terms for Nasal Cavity Lymphoma

Cellular components related to Nasal Cavity Lymphoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	cytosol	GO:0005829	9.73	TIA1 TCOF1 SCYL1 PSMB8 PRF1 NISCH
2	external side of plasma membrane	GO:0009897	9.02	NCAM1 IGHV4-38-2 CD5 CD2 B2M

Biological processes related to Nasal Cavity Lymphoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	negative regulation of cell-matrix adhesion	GO:0001953	9.32	CDKN2A BCL6
2	positive regulation of cellular senescence	GO:2000774	9.26	CDKN2A B2M
3	cytolysis	GO:0019835	9.16	PRF1 GZMB
4	apoptotic process	GO:0006915	9.1	TIA1 PRF1 NISCH GZMB CDKN2A CD2
5	amyloid fibril formation	GO:1990000	8.96	CDKN2A B2M

Sources

Sources for Nasal Cavity Lymphoma

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HMDB

³¹ HPO

³² ICD10

³³ ICD10 via Orphanet

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ KEGG

³⁷ LifeMap

³⁸ LncRNADisease

³⁹ LOVD

⁴⁰ MalaCards

⁴¹ MedGen

⁴² MedlinePlus

⁴³ MeSH

⁴⁴ MESH via Orphanet

⁴⁵ MGI

⁴⁶ miR2Disease

⁴⁷ NCBI Bookshelf

⁴⁸ NCI

⁴⁹ NCIt

⁵⁰ NDF-RT

⁵¹ NIH Clinical Center

⁵² NIH Rare Diseases

⁵³ NINDS

⁵⁴ Novoseek

⁵⁵ Novus Biologicals

⁵⁶ OMIM

⁵⁷ OMIM via Orphanet

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubMed

⁶² PubMed Health

⁶³ QIAGEN

⁶⁴ R&D Systems

⁶⁵ Reactome

⁶⁶ Sino Biological

⁶⁷ SNOMED-CT

⁶⁸ SNOMED-CT via HPO

⁶⁹ TGDB

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ Wikipedia